Datexim – Celebrating its 15th Anniversary

Datexim – Celebrating its 15th Anniversary

Over the past 15 years, Datexim has become a trusted player in digital cytology, driven by innovation and expertise. From being the first IVD certified AI for Cervix in the world in 2017, we are now deployed across Europe with 1 million slides processed in clinical routine. Our team has remained steadfast in our mission to transform digital pathology, and the results speak for themselves.

• Clinical Scale: Reached a major milestone of 1 million cumulative slides processed in clinical routine

  
  

• Product Innovation: Launched the latest CytoProcessor® version, featuring an intuitive new UI, advanced microorganism detection, and seamless bidirectional LIS integration

  
  

• Interoperability: Expanded our hardware compatibility with new AI classifiers fo Evident and Argos scanners

  
  

• Market Expansion: Solidified our presence across the continent with a comprehensive European distribution network

  
  

These milestones firmly position Datexim as a leader in digital cytology and mark a decisive step forward for the company. They give us the confidence, credibility, and momentum to scale our impact across clinical, technical, and commercial domains.

Looking ahead, our focus for the coming year is clear:

• Continuing to build scalable, reliable solutions that support healthcare professionals

  
  

• Accelerating innovation in digital cytology to address evolving clinical needs

  
  

• Strengthening collaborations with laboratories and partners across Europe

  
  

• Increasing our visibility and impact within the international scientific ecosystem

  
  

• Expanding our presence across Europe and beyond

Throughout the year, we will remain committed to what defines Datexim - delivering reliable, innovative solutions that support healthcare professionals and integrate seamlessly into daily clinical practice.

Thank you to our clients, partners, and team members for being part of this journey.